Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II, 2nd Line Melanoma - RAND Monotherapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00612664
First received: January 30, 2008
Last updated: September 23, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 21, 2011